ICD E85.0ORPHA:342FMF

Familial Mediterranean Fever

Familial Mediterranean Fever is the most common hereditary autoinflammatory disease, caused by mutations in the MEFV gene. It causes recurrent episodes of fever and serositis (painful inflammation of the lining of the abdomen, chest, or joints). It predominantly affects people of Mediterranean and Middle Eastern descent. Colchicine is highly effective in preventing attacks and reducing amyloid risk.

657
Articles
67
Trials (2 AU)
Updated
5 April 2026
Loading...

Common Questions

What is Familial Mediterranean Fever?

Familial Mediterranean Fever is the most common hereditary autoinflammatory disease, caused by mutations in the MEFV gene. It causes recurrent episodes of fever and serositis (painful inflammation of the lining of the abdomen, chest, or joints). It predominantly affects people of Mediterranean and Middle Eastern descent. Colchicine is highly effective in preventing attacks and reducing amyloid risk.

How many clinical trials are available for Familial Mediterranean Fever?

RareWays currently indexes 67 clinical trials for Familial Mediterranean Fever, of which 14 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Familial Mediterranean Fever come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Familial Mediterranean Fever.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.